Ledger.Open graph →
SEC Form D · filed December 5, 2017

ADIAL PHARMACEUTICALS, INC

Offering
$100K
Sold
$100K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CHARLOTTESVILLE, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

James K. Anderson · Charlottesville, VADirectorJoseph M. Truluck · Charlottesville, VAExecWilliam B. Stilley, Iii · Charlottesville, VAExec · DirectorBankole A. Johnson · Charlottesville, VADirectorRobertson H. Gilliland · Charlottesville, VADirectorGina Mondo · Norwich, CTExec · DirectorJesse S. Jacobs · Playa Vista, CADirectorW. C. Mccollum · Los Angeles, CAExecJason Bergsman · Playa Vista, CADirectorMike Kerns · Playa Vista, CADirectorUrsula Newman · London, United KingdomDirectorThomas Scriven · Golden, CODirectorMatthew Davis · Purcellville, VADirectorFred Ausubel · Allston, MAExecIsaac Stoner · Allston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗